Hudson Bay Capital Management LP Buys $3.93M Stake in Sotera Health

The hedge fund now owns about 0.09% of the medical services company.

Mar. 22, 2026 at 8:41am

Got story updates? Submit your updates here. ›

Hudson Bay Capital Management LP bought a new stake of 250,000 shares in Sotera Health Company (NASDAQ:SHC) during the third quarter, according to a recent SEC filing. The stake is valued at approximately $3.93 million, making Hudson Bay Capital Management LP a new significant shareholder owning about 0.09% of Sotera Health.

Why it matters

Sotera Health is a major provider of sterilization and lab testing services for the medical device, pharmaceutical, and consumer product industries. Hudson Bay Capital Management's investment signals confidence in the company's business model and growth potential within these critical industries.

The details

According to the SEC filing, Hudson Bay Capital Management purchased the 250,000 shares of Sotera Health in the third quarter. This new stake represents about 0.09% ownership in the company. Several other large institutional investors have also recently bought and sold Sotera Health shares, including the Arizona State Retirement System, Legal & General Group Plc, and Federated Hermes Inc.

  • Hudson Bay Capital Management purchased the Sotera Health shares in the third quarter of 2026.

The players

Hudson Bay Capital Management LP

A hedge fund that has now taken a $3.93 million stake in Sotera Health, representing about 0.09% ownership in the company.

Sotera Health Company

A global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries.

Got photos? Submit your photos here. ›

The takeaway

Hudson Bay Capital Management's investment in Sotera Health signals confidence in the company's critical role serving highly regulated industries like medical devices and pharmaceuticals. As a major provider of sterilization and testing services, Sotera Health's business model appears to be resonating with institutional investors.